This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Active Biotech AB
Drug Names(s): ABR-215757, paquinimod
Description: ABR-215757 is a small molecule compound intended for the treatment of chronic SLE. Thecompound belongs to the quinoline 3-carboxamides, a group of immunomodulators interacting with a defined target, S100A9 causing reduction of autoreactive T-cell proliferation without general immune suppression. Multiple disease parameters including serological disease markers and histopathological manifestations are affected by ABR-215757.
Pink Sheet Global Pharma Guidance Tracker – August 2018
Additional information available to subscribers only: